• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Effect of Filter Lifespan during Continuous Renal Replacement Therapy in Critically Ill Patients with Acute Kidney Injury on the Rate of New-Onset Infection: Analysis from the RICH Randomized Controlled Trial.

作者信息

Gerss Joachim, Meersch Melanie, Kindgen-Milles Detlef, Brandenburger Timo, Willam Carsten, Kellum John A, Zarbock Alexander

机构信息

University of Münster Münster, Germany.

Heinrich-Heine University of Düsseldorf Düsseldorf, Germany.

出版信息

Am J Respir Crit Care Med. 2022 Aug 15;206(4):511-514. doi: 10.1164/rccm.202201-0063LE.

DOI:10.1164/rccm.202201-0063LE
PMID:35549654
Abstract
摘要

相似文献

1
The Effect of Filter Lifespan during Continuous Renal Replacement Therapy in Critically Ill Patients with Acute Kidney Injury on the Rate of New-Onset Infection: Analysis from the RICH Randomized Controlled Trial.连续性肾脏替代治疗期间滤器使用寿命对急性肾损伤危重症患者新发感染率的影响：来自RICH随机对照试验的分析
Am J Respir Crit Care Med. 2022 Aug 15;206(4):511-514. doi: 10.1164/rccm.202201-0063LE.
2
Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.局部枸橼酸抗凝与全身肝素抗凝对连续性肾脏替代治疗中急性肾损伤危重症患者透析滤器寿命和死亡率的影响：一项随机临床试验。
JAMA. 2020 Oct 27;324(16):1629-1639. doi: 10.1001/jama.2020.18618.
3
Continuous renal replacement therapy without anticoagulation in critically ill patients at high risk of bleeding: A systematic review and meta-analysis.危重症出血高风险患者无抗凝连续肾脏替代治疗：系统评价和荟萃分析。
Semin Dial. 2021 May;34(3):196-208. doi: 10.1111/sdi.12946. Epub 2021 Jan 5.
4
How do filter types of renal replacement therapy affect survival in critically ill patients? Concerns about adsorption of nafamostat mesylate on AN69 membranes.不同类型肾脏替代治疗方式对危重症患者的生存率有何影响？关注甲磺酸萘莫司他在 AN69 膜上的吸附作用。
BMC Nephrol. 2024 Sep 20;25(1):314. doi: 10.1186/s12882-024-03745-1.
5
A feasible strategy for preventing blood clots in critically ill patients with acute kidney injury (FBI): study protocol for a randomized controlled trial.一种预防急性肾损伤危重症患者血栓形成的可行策略（FBI）：一项随机对照试验的研究方案
Trials. 2014 Jun 13;15:226. doi: 10.1186/1745-6215-15-226.
6
Fluid Overload Associates With Major Adverse Kidney Events in Critically Ill Patients With Acute Kidney Injury Requiring Continuous Renal Replacement Therapy.在需要连续肾脏替代治疗的急性肾损伤危重症患者中，液体超负荷与主要不良肾脏事件相关。
Crit Care Med. 2019 Sep;47(9):e753-e760. doi: 10.1097/CCM.0000000000003862.
7
Review of Anticoagulation in Continuous Renal Replacement Therapy.连续肾脏替代治疗中的抗凝治疗综述。
Crit Care Nurs Q. 2022;45(2):144-155. doi: 10.1097/CNQ.0000000000000397.
8
The Effect of Patient- and Treatment-Related Factors on Circuit Lifespan During Continuous Renal Replacement Therapy in Critically Ill Children.患者和治疗相关因素对危重症儿童连续性肾脏替代治疗中回路寿命的影响。
Pediatr Crit Care Med. 2020 Jun;21(6):578-585. doi: 10.1097/PCC.0000000000002305.
9
Epoprostenol (Prostacyclin Analog) as a Sole Anticoagulant in Continuous Renal Replacement Therapy for Critically Ill Children With Liver Disease: Single-Center Retrospective Study, 2010-2019: Erratum.依前列醇（前列环素类似物）作为肝病重症患儿持续肾脏替代治疗中的单一抗凝剂：单中心回顾性研究，2010 - 2019年：勘误
Pediatr Crit Care Med. 2024 Mar 1;25(3):e175. doi: 10.1097/PCC.0000000000003472. Epub 2024 Mar 4.
10
Association of Net Ultrafiltration Rate With Mortality Among Critically Ill Adults With Acute Kidney Injury Receiving Continuous Venovenous Hemodiafiltration: A Secondary Analysis of the Randomized Evaluation of Normal vs Augmented Level (RENAL) of Renal Replacement Therapy Trial.网络超滤率与接受连续性静脉-静脉血液滤过治疗的急性肾损伤危重症成人死亡率的相关性：肾脏替代治疗随机评估正常 vs 增强水平（RENAL）试验的二次分析。
JAMA Netw Open. 2019 Jun 5;2(6):e195418. doi: 10.1001/jamanetworkopen.2019.5418.

引用本文的文献

1
[Ten key messages from the S3 guideline for evidence-based renal replacement therapy in intensive care medicine].[重症医学中基于证据的肾脏替代治疗S3指南的十条关键信息]
Med Klin Intensivmed Notfmed. 2025 Jun 26. doi: 10.1007/s00063-025-01297-2.
2
[S3 guideline on renal replacement therapy in intensive care medicine : Evidence-based implementation of renal replacement therapy in critically ill patients].[重症医学中肾脏替代治疗的S3指南：危重症患者肾脏替代治疗的循证实施]
Med Klin Intensivmed Notfmed. 2025 Jun 23. doi: 10.1007/s00063-025-01293-6.
3
Ten tips on how to reduce iatrogenic acute kidney injury.
关于如何减少医源性急性肾损伤的十条建议。
Clin Kidney J. 2024 Dec 18;18(2):sfae412. doi: 10.1093/ckj/sfae412. eCollection 2025 Feb.
4
Continuous kidney replacement therapy in critically ill children: heparin vs citrate.危重症儿童的持续肾脏替代治疗：肝素与枸橼酸盐对比
Pediatr Res. 2024 Aug;96(3):563-564. doi: 10.1038/s41390-024-03238-9. Epub 2024 May 13.
5
Rapid implementation of an emergency on-site CKRT dialysate production system during the COVID-19 pandemic.在 COVID-19 大流行期间，快速实施紧急现场 CKRT 透析液生产系统。
BMC Nephrol. 2023 Aug 22;24(1):245. doi: 10.1186/s12882-023-03260-9.
6
Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.危重症患者连续性肾脏替代治疗的抗凝选择：系统评价和网络荟萃分析的随机对照试验。
Crit Care. 2023 Jun 7;27(1):222. doi: 10.1186/s13054-023-04519-1.
7
Continuous KRT: A Contemporary Review.持续肾脏替代治疗：当代综述。
Clin J Am Soc Nephrol. 2023 Feb 1;18(2):256-269. doi: 10.2215/CJN.04350422. Epub 2022 Aug 18.